PSORS1C1, psoriasis susceptibility 1 candidate 1, 170679
N. diseases: 43; N. variants: 96
Source: ALL
Variant | DSI v | DPI v | Chr | Position | Consequence | Alleles | Class | AF EXOME | AF GENOME | Disease | Disease Class | Score vda | EI vda | N. PMIDs | First Ref. | Last Ref. | ||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
0.827 | 0.320 | 6 | 31113428 | upstream gene variant | T/C | snv | 0.12 |
|
Neoplasms; Respiratory Tract Diseases | 0.700 | 1.000 | 1 | 2012 | 2012 | |||||||
|
0.827 | 0.320 | 6 | 31113428 | upstream gene variant | T/C | snv | 0.12 |
|
Nutritional and Metabolic Diseases; Immune System Diseases; Endocrine System Diseases | 0.700 | 1.000 | 1 | 2007 | 2007 | |||||||
|
0.827 | 0.320 | 6 | 31113428 | upstream gene variant | T/C | snv | 0.12 |
|
Neoplasms; Immune System Diseases; Nervous System Diseases | 0.700 | 1.000 | 1 | 2012 | 2012 | |||||||
|
0.827 | 0.320 | 6 | 31113428 | upstream gene variant | T/C | snv | 0.12 |
|
Neoplasms; Respiratory Tract Diseases | 0.700 | 1.000 | 1 | 2017 | 2017 | |||||||
|
0.827 | 0.320 | 6 | 31113428 | upstream gene variant | T/C | snv | 0.12 |
|
Female Urogenital Diseases and Pregnancy Complications; Male Urogenital Diseases; Immune System Diseases | 0.700 | 1.000 | 1 | 2011 | 2011 | |||||||
|
1.000 | 0.120 | 6 | 31113632 | upstream gene variant | T/C | snv | 0.35 |
|
Skin and Connective Tissue Diseases; Musculoskeletal Diseases; Immune System Diseases | 0.700 | 1.000 | 1 | 2007 | 2007 | |||||||
|
1.000 | 0.080 | 6 | 31113657 | upstream gene variant | A/G | snv | 9.7E-02 |
|
Neoplasms; Respiratory Tract Diseases | 0.700 | 1.000 | 1 | 2017 | 2017 | |||||||
|
0.925 | 0.080 | 6 | 31114061 | upstream gene variant | C/T | snv | 0.27 |
|
0.700 | 1.000 | 1 | 2010 | 2010 | ||||||||
|
0.925 | 0.080 | 6 | 31114061 | upstream gene variant | C/T | snv | 0.27 |
|
0.700 | 1.000 | 1 | 2010 | 2010 | ||||||||
|
0.925 | 0.080 | 6 | 31114061 | upstream gene variant | C/T | snv | 0.27 |
|
0.700 | 1.000 | 1 | 2010 | 2010 | ||||||||
|
0.925 | 0.080 | 6 | 31114061 | upstream gene variant | C/T | snv | 0.27 |
|
0.700 | 1.000 | 1 | 2010 | 2010 | ||||||||
|
0.925 | 0.080 | 6 | 31114061 | upstream gene variant | C/T | snv | 0.27 |
|
Immune System Diseases; Nervous System Diseases | 0.700 | 1.000 | 1 | 2007 | 2007 | |||||||
|
1.000 | 0.120 | 6 | 31114584 | upstream gene variant | C/T | snv | 0.16 |
|
Skin and Connective Tissue Diseases; Musculoskeletal Diseases; Immune System Diseases | 0.700 | 1.000 | 1 | 2009 | 2009 | |||||||
|
1.000 | 6 | 31115379 | 3 prime UTR variant | A/G | snv | 0.58 |
|
0.700 | 1.000 | 1 | 2010 | 2010 | |||||||||
|
1.000 | 6 | 31115379 | 3 prime UTR variant | A/G | snv | 0.58 |
|
0.700 | 1.000 | 1 | 2010 | 2010 | |||||||||
|
1.000 | 6 | 31115379 | 3 prime UTR variant | A/G | snv | 0.58 |
|
0.700 | 1.000 | 1 | 2010 | 2010 | |||||||||
|
1.000 | 6 | 31115379 | 3 prime UTR variant | A/G | snv | 0.58 |
|
0.700 | 1.000 | 1 | 2010 | 2010 | |||||||||
|
1.000 | 6 | 31115879 | 3 prime UTR variant | G/A | snv | 0.58 |
|
0.700 | 1.000 | 1 | 2010 | 2010 | |||||||||
|
1.000 | 6 | 31115879 | 3 prime UTR variant | G/A | snv | 0.58 |
|
0.700 | 1.000 | 1 | 2010 | 2010 | |||||||||
|
1.000 | 6 | 31115879 | 3 prime UTR variant | G/A | snv | 0.58 |
|
0.700 | 1.000 | 1 | 2010 | 2010 | |||||||||
|
1.000 | 6 | 31115879 | 3 prime UTR variant | G/A | snv | 0.58 |
|
0.700 | 1.000 | 1 | 2010 | 2010 | |||||||||
|
1.000 | 6 | 31115887 | 3 prime UTR variant | G/A | snv | 0.58 |
|
0.700 | 1.000 | 1 | 2010 | 2010 | |||||||||
|
1.000 | 6 | 31115887 | 3 prime UTR variant | G/A | snv | 0.58 |
|
0.700 | 1.000 | 1 | 2010 | 2010 | |||||||||
|
1.000 | 6 | 31115887 | 3 prime UTR variant | G/A | snv | 0.58 |
|
0.700 | 1.000 | 1 | 2010 | 2010 | |||||||||
|
1.000 | 6 | 31115887 | 3 prime UTR variant | G/A | snv | 0.58 |
|
0.700 | 1.000 | 1 | 2010 | 2010 |